Latest Valuation News

Dexus has reported a statutory net profit of $10.3 million for the half-year ending December 2024, rebounding from a significant loss last year, while maintaining strong portfolio occupancy and confirming steady distributions.

Dexus (ASX: DXS) reports a statutory net profit of $10.3 million for the half-year ending December 2024, rebounding from a significant loss last year, while navigating challenges from higher interest rates and lower trading profits.

Infomedia Ltd reported a steady 2% revenue increase and an 11% rise in NPATA for H1 FY25, alongside a strategic 50% stake acquisition in European AI startup Intellegam, signaling a push for innovation and global expansion.

Lincoln Minerals is accelerating development across its diversified portfolio of critical minerals projects in South Australia's Gawler Craton, targeting copper, uranium, graphite, and high-purity iron to meet global electrification and decarbonization demands.

HMC Capital Limited has reported a remarkable 680% increase in profit for the half-year ended 31 December 2024, driven by key acquisitions and expansion into digital infrastructure and private credit sectors. The company also announced a fully franked interim dividend, underscoring confidence in its growth trajectory.

Monadelphous Group Limited has reported a robust 41.33% increase in profit after tax for the half-year ending December 2024, alongside a modest 2.05% rise in revenue and a significant hike in its interim dividend.

Challenger Limited reported a robust first half of FY25 with a 12% rise in normalized NPAT and a 12% increase in its interim dividend, driven by strong annuity sales and strategic technology investments.

Infratil has increased its investment in CDC Data Centres by acquiring an additional 1.58% stake for approximately A$216 million, reinforcing its commitment to the fast-growing digital infrastructure sector.

Kina Securities confirms its 2024 underlying profit guidance amid a non-cash statutory profit reduction driven by deferred tax asset adjustments and a customer fraud impact.

Future Metals NL has addressed an ASX price query by confirming the release of drilling results from its Eileen Bore Prospect, attributing recent trading activity to investor anticipation and compliance with disclosure rules.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.

Perpetual Limited has received updated, non-binding proposals from KKR for its Wealth Management and Corporate Trust businesses, but key terms and shareholder proceeds remain uncertain.